These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 15100298)

  • 1. Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity.
    La Gruta NL; Turner SJ; Doherty PC
    J Immunol; 2004 May; 172(9):5553-60. PubMed ID: 15100298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential tumor necrosis factor receptor 2-mediated editing of virus-specific CD8+ effector T cells.
    Turner SJ; La Gruta NL; Stambas J; Diaz G; Doherty PC
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3545-50. PubMed ID: 14993609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixing an irrelevant TCR alpha chain reveals the importance of TCR beta diversity for optimal TCR alpha beta pairing and function of virus-specific CD8+ T cells.
    Valkenburg SA; Day EB; Swan NG; Croom HA; Carbone FR; Doherty PC; Turner SJ; Kedzierska K
    Eur J Immunol; 2010 Sep; 40(9):2470-81. PubMed ID: 20690181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responses.
    Belz GT; Xie W; Doherty PC
    J Immunol; 2001 Apr; 166(7):4627-33. PubMed ID: 11254721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge.
    Crowe SR; Miller SC; Shenyo RM; Woodland DL
    J Immunol; 2005 Jan; 174(2):696-701. PubMed ID: 15634888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The context of epitope presentation can influence functional quality of recalled influenza A virus-specific memory CD8+ T cells.
    Day EB; Zeng W; Doherty PC; Jackson DC; Kedzierska K; Turner SJ
    J Immunol; 2007 Aug; 179(4):2187-94. PubMed ID: 17675478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection.
    Wiley JA; Hogan RJ; Woodland DL; Harmsen AG
    J Immunol; 2001 Sep; 167(6):3293-9. PubMed ID: 11544317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses.
    Belz GT; Stevenson PG; Doherty PC
    J Immunol; 2000 Sep; 165(5):2404-9. PubMed ID: 10946264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of MHC class I diversification on influenza epitope-specific CD8+ T cell precursor frequency and subsequent effector function.
    Day EB; Charlton KL; La Gruta NL; Doherty PC; Turner SJ
    J Immunol; 2011 Jun; 186(11):6319-28. PubMed ID: 21536802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of T cell receptor affinity to overall avidity for virus-specific CD8+ T cell responses.
    Kedzierska K; La Gruta NL; Davenport MP; Turner SJ; Doherty PC
    Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11432-7. PubMed ID: 16061802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional heterogeneity of type 1 effector T cells in response to infection is related to the potential for IFN-gamma production.
    Mayer KD; Mohrs K; Crowe SR; Johnson LL; Rhyne P; Woodland DL; Mohrs M
    J Immunol; 2005 Jun; 174(12):7732-9. PubMed ID: 15944275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of CD8+ T cells expressing NK cell receptors in influenza A virus-infected mice.
    Kambayashi T; Assarsson E; Michaëlsson J; Berglund P; Diehl AD; Chambers BJ; Ljunggren HG
    J Immunol; 2000 Nov; 165(9):4964-9. PubMed ID: 11046023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of a prominent epitope affects influenza A virus-specific CD8+ T cell immunodominance hierarchies when antigen is limiting.
    Jenkins MR; Webby R; Doherty PC; Turner SJ
    J Immunol; 2006 Sep; 177(5):2917-25. PubMed ID: 16920927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections.
    Hogan RJ; Usherwood EJ; Zhong W; Roberts AA; Dutton RW; Harmsen AG; Woodland DL
    J Immunol; 2001 Feb; 166(3):1813-22. PubMed ID: 11160228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration.
    Betts MR; Price DA; Brenchley JM; Loré K; Guenaga FJ; Smed-Sorensen A; Ambrozak DR; Migueles SA; Connors M; Roederer M; Douek DC; Koup RA
    J Immunol; 2004 May; 172(10):6407-17. PubMed ID: 15128832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope-specific regulation of memory programming by differential duration of antigen presentation to influenza-specific CD8(+) T cells.
    Ballesteros-Tato A; León B; Lee BO; Lund FE; Randall TD
    Immunity; 2014 Jul; 41(1):127-40. PubMed ID: 25035957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.
    Cerwenka A; Morgan TM; Dutton RW
    J Immunol; 1999 Nov; 163(10):5535-43. PubMed ID: 10553081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold.
    Valkenburg SA; Gras S; Guillonneau C; La Gruta NL; Thomas PG; Purcell AW; Rossjohn J; Doherty PC; Turner SJ; Kedzierska K
    PLoS Pathog; 2010 Aug; 6(8):e1001039. PubMed ID: 20711359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccines, combining form of antigen and method of delivery to raise a spectrum of IFN-gamma and IL-4-producing CD4+ and CD8+ T cells.
    Oran AE; Robinson HL
    J Immunol; 2003 Aug; 171(4):1999-2005. PubMed ID: 12902504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consequences of suboptimal priming are apparent for low-avidity T-cell responses.
    Venturi V; Davenport MP; Swan NG; Doherty PC; Kedzierska K
    Immunol Cell Biol; 2012 Feb; 90(2):216-23. PubMed ID: 21556018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.